葡萄膜黑色素瘤中Gα蛋白GNA11突变较GNAQ突变与更短疾病特异性生存及更强BAP1缺失和染色体改变相关
该研究分析219例葡萄膜黑色素瘤中GNAQ与GNA11突变与疾病特异性生存、基因表达谱及细胞遗传学改变的关系,发现GNA11突变与BAP1表达缺失、3号染色体单体、8q扩增及后两者组合正相关,与6p获得负相关,且GNA11突变者疾病特异性生存较GNAQ突变者更短(HR=1.97)。
要点
- GNA11突变与BAP1表达缺失频率增加相关(p=0.0005)。
- GNA11突变者疾病特异性生存较GNAQ突变者更短(HR=1.97,95%CI 1.12-3.46,p=0.02)。
- GNAQ蛋白与TET2物理互作而GNA11蛋白不与TET2互作。
核心结论
- GNA11突变的葡萄膜黑色素瘤预后更差,并与高风险细胞遗传学、突变及分子肿瘤特征相关,这些特征至少部分可能由DNA甲基化差异调控决定。
研究设计与样本
- 研究分析了219例葡萄膜黑色素瘤中GNAQ与GNA11突变与疾病特异性生存、基因表达谱及细胞遗传学改变的关系。
- 采用串联亲和纯化、质谱和免疫共沉淀鉴定两种G蛋白的蛋白互作伙伴,并分析其对DNA甲基化的影响。
主要发现
- GNA11突变与BAP1表达缺失频率增加相关(p=0.0005)。
- GNA11突变与3号染色体单体相关(p<0.001)。
- GNA11突变与8q扩增相关(p=0.038)。
- GNA11突变与3号染色体单体合并8q扩增相关(p=0.0002),与6p获得呈负相关(p=0.003)。
- GNA11突变病例疾病特异性生存较GNAQ突变病例更短(HR=1.97,95%CI 1.12-3.46,p=0.02)。
关键数值与推荐
- GNA11突变与BAP1表达缺失频率增加相关(p=0.0005)。
- GNA11突变与3号染色体单体相关(p<0.001)。
- GNA11突变与8q扩增相关(p=0.038)。
- GNA11突变与3号染色体单体合并8q扩增相关(p=0.0002),与6p获得呈负相关(p=0.003)。
- GNA11突变病例疾病特异性生存较GNAQ突变病例更短(HR=1.97,95%CI 1.12-3.46,p=0.02)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIM OF THE STUDY: Mutations in the Gα-genes GNAQ and GNA11 are found in 85-90% of uveal melanomas (UM). Aim of the study is to understand whether the mutations in both genes differentially affect tumor characteristics and outcome and if so, to identify potential mechanisms. METHODS: We analyzed the association between GNAQ and GNA11 mutations with disease-specific survival, gene expression profiles, and cytogenetic alterations in 219 UMs. We used tandem-affinity-purification, mass spectrometry and immunoprecipitation to identify protein interaction partners of the two G-proteins and analyzed their impact on DNA-methylation. RESULTS: GNA11 mutation was associated with: i) an increased frequency of loss of BRCA1-associated protein 1 (BAP1) expression (p = 0.0005), ii) monosomy of chromosome 3 (p < 0.001), iii) amplification of chr8q (p = 0.038), iv) the combination of the latter two (p = 0.0002), and inversely with v) chr6p gain (p = 0.003). Our analysis also showed a shorter disease-specific survival of GNA11-mutated cases as compared to those carrying a GNAQ mutation (HR = 1.97 [95%CI 1.12-3.46], p = 0.02). GNAQ and GNA11 encoded G-proteins have different protein interaction partners. Specifically, the Tet Methylcytosine Dioxygenase 2 (TET2), a protein that is involved in DNA demethylation, physically interacts with the GNAQ protein but not with GNA11, as confirmed by immunoprecipitation analyses. High-risk UM cases show a clearly different DNA-methylation pattern, suggesting that a different regulation of DNA methylation by the two G-proteins might convey a different risk of progression. CONCLUSIONS: GNA11 mutated uveal melanoma has worse prognosis and is associated with high risk cytogenetic, mutational and molecular tumor characteristics that might be determined at least in part by differential DNA-methylation.
引用
- Piaggio F, Croce M, Reggiani F, et al. In uveal melanoma Gα-protein GNA11 mutations convey a shorter disease-specific survival and are more strongly associated with loss of BAP1 and chromosomal alterations than Gα-protein GNAQ mutations. Eur J Cancer. 2022. PMID: 35580369. doi:10.1016/j.ejca.2022.04.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。